← Back to Healthcare

Biotechnology

Industry Overview

Stock Screener

Select filters to narrow down the 1019 companies below

1019 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Samsung Biologics Co.,Ltd.

207940.KS

Samsung Biologics Co.,Ltd.

207940.KS
Market Cap $68.25T
Dividends 0.0%
P/E Ratio 37.7
Revenue $1.49T -10.2%
Net Income $391B -31.9%
Profit Margin +26.2%
Employees 5.46K
View Stock

Celltrion, Inc.

068270.KS

Celltrion, Inc.

068270.KS
Market Cap $44.34T
Dividends 0.4%
P/E Ratio 28.1
Revenue $1.39T
Net Income $371B
Profit Margin +26.6%
Employees 3.15K
View Stock

Alteogen Inc.

196170.KQ

Alteogen Inc.

196170.KQ
Market Cap $15.63T
Dividends 0.2%
P/E Ratio 71.3
Revenue $68.9B
Net Income $28.4B
Profit Margin +41.2%
Employees 161
View Stock

Samsung Epis Holdings

0126Z0.KS

Samsung Epis Holdings

0126Z0.KS
Market Cap $8.25T
Dividends 0.0%
P/E Ratio 94.5
Revenue $301M
Net Income $65.9M
Profit Margin +21.9%
Employees 9
View Stock

SK Biopharmaceuticals Co., Ltd.

326030.KS

SK Biopharmaceuticals Co., Ltd.

326030.KS
Market Cap $6.02T
Dividends 0.0%
P/E Ratio 15.5
Revenue $247B
Net Income $85.1B
Profit Margin +34.4%
Employees 241
View Stock

HLB Co., Ltd.

028300.KQ

HLB Co., Ltd.

028300.KQ
Market Cap $5.53T
Dividends 0.0%
P/E Ratio -25.8
Revenue $28B
Net Income -$77B
Profit Margin -274.8%
Employees 151
View Stock

SK bioscience Co.,Ltd.

302440.KS

SK bioscience Co.,Ltd.

302440.KS
Market Cap $2.6T
Dividends 0.0%
P/E Ratio -31.1
Revenue $156B
Net Income -$14.1B
Profit Margin -9.0%
Employees 984
View Stock

LigaChem Biosciences Inc.

141080.KQ

LigaChem Biosciences Inc.

141080.KQ
Market Cap $2.51T
Dividends 0.0%
P/E Ratio -12.7
Revenue $5.53B
Net Income -$71.2B
Profit Margin -1286.9%
Employees 180
View Stock

ABL Bio Inc.

298380.KQ

ABL Bio Inc.

298380.KQ
Market Cap $2.48T
Dividends 0.0%
P/E Ratio -30.7
Revenue $19.7B
Net Income -$14.7B
Profit Margin -74.7%
Employees 102
View Stock

Voronoi, Inc.

310210.KQ

Voronoi, Inc.

310210.KQ
Market Cap $2.44T
Dividends 0.0%
P/E Ratio -32.5
Revenue $0.00
Net Income -$29B
Profit Margin
Employees 149
View Stock

Peptron, Inc.

087010.KQ

Peptron, Inc.

087010.KQ
Market Cap $2.43T
Dividends 0.0%
P/E Ratio -118.4
Revenue $1.45B
Net Income -$7.71B
Profit Margin -533.7%
Employees 163
View Stock

OliX Pharmaceuticals,Inc

226950.KQ

OliX Pharmaceuticals,Inc

226950.KQ
Market Cap $2.35T
Dividends 0.0%
P/E Ratio -171.3
Revenue $2.62B
Net Income -$11B
Profit Margin -418.6%
Employees 76
View Stock

Hugel, Inc.

145020.KQ

Hugel, Inc.

145020.KQ
Market Cap $1.95T
Dividends 0.0%
P/E Ratio 13.0
Revenue $138B
Net Income $43.3B
Profit Margin +31.4%
Employees 629
View Stock

D&D Pharmatech

347850.KQ

D&D Pharmatech

347850.KQ
Market Cap $1.87T
Dividends 0.0%
P/E Ratio -80.9
Revenue $662M
Net Income -$8.27B
Profit Margin -1249.5%
Employees 22
View Stock

Kolon TissueGene, Inc.

950160.KQ

Kolon TissueGene, Inc.

950160.KQ
Market Cap $1.31T
Dividends 0.0%
P/E Ratio -7.0
Revenue $829M
Net Income $50.3B
Profit Margin +6060.2%
Employees 58
View Stock

Bioneer Corporation

064550.KQ

Bioneer Corporation

064550.KQ
Market Cap $899.49B
Dividends 0.0%
P/E Ratio -9.3
Revenue $88.3B
Net Income -$1.1B
Profit Margin -1.3%
Employees 608
View Stock

Bioneer Corp

064550.KS

Bioneer Corp

064550.KS
Market Cap $899.49B
Dividends 0.0%
P/E Ratio -9.3
Revenue $88.3B
Net Income -$1.1B
Profit Margin -1.3%
Employees 608
View Stock

Chabiotech Co.,Ltd.

085660.KQ

Chabiotech Co.,Ltd.

085660.KQ
Market Cap $662.32B
Dividends 0.0%
P/E Ratio 77.9
Revenue $316B
Net Income $29.3B
Profit Margin +9.2%
Employees 354
View Stock

Komipharm International Co., Ltd.

041960.KQ

Komipharm International Co., Ltd.

041960.KQ
Market Cap $619.61B
Dividends 0.0%
P/E Ratio -240.8
Revenue $16.7B
Net Income $618M
Profit Margin +3.7%
Employees 172
View Stock

Hyundai Bioscience Co., Ltd.

048410.KQ

Hyundai Bioscience Co., Ltd.

048410.KQ
Market Cap $615.69B
Dividends 0.0%
P/E Ratio -23.2
Revenue $520M
Net Income -$9.4B
Profit Margin -1807.1%
Employees 54
View Stock